245 filings
Page 3 of 13
8-K
xynnv
4 Oct 22
Regulation FD Disclosure
7:35am
8-K
ma6av1ukpulj9s
28 Sep 22
Regulation FD Disclosure
1:42pm
8-K
4tm9f8ynzq
26 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
7rh614g9dwy8le8t amg
20 Sep 22
Regulation FD Disclosure
7:34am
8-K
k7oy36m45
17 Aug 22
Regulation FD Disclosure
4:31pm
8-K
3v3vq4 oht
15 Aug 22
Departure of Directors or Certain Officers
5:53pm
8-K
o7yg2kjeq gd8d24ql2
11 Aug 22
Wave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
7:36am
8-K
iavjl abwtpifnqh
14 Jun 22
Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
9:32am
424B5
jtyv1bfsfrc6e5l
14 Jun 22
Prospectus supplement for primary offering
9:24am
8-K
0uooba efylph
12 May 22
Wave Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
7:40am
EFFECT
hl97 l34m073i
5 May 22
Notice of effectiveness
12:15am
CORRESP
ongkqqp
2 May 22
Correspondence with SEC
12:00am
8-K
z67zn33wr3l03173wb7
4 Apr 22
Reductions in poly(GP), a key disease biomarker indicating target engagement, observed across all treatment groups after single doses
7:35am
UPLOAD
jm6f oq7ix1a
7 Mar 22
Letter from SEC
12:00am
8-K
ydr2yufmpf7tlxuvrnnr
3 Mar 22
Entry into a Material Definitive Agreement
4:03pm